The company will acquire Dr Reddy's Laboratories' anti-bacterial medicines under the Ciprolet and Levolet brands in Russia, Uzbekistan and Belarus. The product portfolio includes various dosage forms such as tablets, solution for infusions and eye drops.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/lKMC5zt
No comments:
Post a Comment